Robyn P. Saw - Publications

Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 06, 2026

Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanoma.

Journal: Journal of the National Cancer Institute

Published: January 29, 2026

Uptake of sentinel lymph node biopsy following a melanoma diagnosis: an Australian population-based study.

Journal: Surgical oncology

Published: December 14, 2025

Timing of Definitive Surgical Management of Primary Cutaneous Melanoma: Association With Survival.

Journal: ANZ journal of surgery

Published: September 24, 2025

Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trial.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 03, 2025

Patient-Reported Outcome Measures and Validation Data Used in Melanoma Research and Routine Practice: A Systematic Review.

Journal: JAMA dermatology

Published: July 30, 2025

A dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 27, 2025

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Journal: Nature medicine

Published: July 10, 2025

A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol.

Journal: PloS one

Published: April 19, 2025

Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma.

Journal: JAMA dermatology

Published: April 09, 2025

Nodal radioactivity after lymphoscintigraphy as a guide to sentinel node-positivity in melanoma patients.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 13, 2025

FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.

Journal: Journal for immunotherapy of cancer

Published: March 10, 2025